CIK 0001133869 · Non-accelerated filer<br>Smaller reporting company
CAPRICOR THERAPEUTICS, INC.
Sign in to watch- Ticker
- CAPR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (310) 358-3200
- Business address
- 10865 ROAD TO THE CURE, SUITE 150, SAN DIEGO, CA, 92121
- Former names
- Nile Therapeutics, Inc., SMI PRODUCTS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 97 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-02-12 | Bergmann Anthony CHIEF FINANCIAL OFFICER | Grant or award · Stock Option (Right to Buy) | +3,500 | 3,500 | ||
| 2020-02-12 | Bergmann Anthony CHIEF FINANCIAL OFFICER | Grant or award · Stock Option (Right to Buy) | +3,000 | 3,000 | ||
| 2020-02-12 | Bergmann Anthony CHIEF FINANCIAL OFFICER | Grant or award · Stock Option (Right to Buy) | +2,500 | 2,500 | ||
| 2020-02-12 | Bergmann Anthony CHIEF FINANCIAL OFFICER | Grant or award · Stock Option (Right to Buy) | +2,178 | 2,178 | ||
| 2020-02-12 | Bergmann Anthony CHIEF FINANCIAL OFFICER | Returned to the company · Stock Option (Right to Buy) | −14,000 | 0 | ||
| 2020-02-12 | Bergmann Anthony CHIEF FINANCIAL OFFICER | Returned to the company · Stock Option (Right to Buy) | −5,000 | 0 | ||
| 2020-02-12 | Bergmann Anthony CHIEF FINANCIAL OFFICER | Returned to the company · Stock Option (Right to Buy) | −3,500 | 0 | ||
| 2020-02-12 | Bergmann Anthony CHIEF FINANCIAL OFFICER | Returned to the company · Stock Option (Right to Buy) | −3,000 | 0 | ||
| 2020-02-12 | Bergmann Anthony CHIEF FINANCIAL OFFICER | Returned to the company · Stock Option (Right to Buy) | −2,500 | 0 | ||
| 2020-02-12 | Bergmann Anthony CHIEF FINANCIAL OFFICER | Returned to the company · Stock Option (Right to Buy) | −2,178 | 0 | ||
| 2019-12-17 | Litvack Frank Director | Grant or award | +20,391 | 20,391 | ||
| 2019-12-17 | Litvack Frank Director | Grant or award · Warrants (Right to Buy) | +20,391 | 20,391 | ||
| 2019-12-17 | Musket David B Director | Grant or award | +20,391 | 22,891 | ||
| 2019-12-17 | Musket David B Director | Grant or award · Warrants (Right to Buy) | +20,391 | 20,391 | ||
| 2019-12-17 | Manzo Louis Director | Grant or award | +20,391 | 36,304 | ||
| 2019-12-17 | Manzo Louis Director | Grant or award · Warrants (Right to Buy) | +20,391 | 20,391 | ||
| 2019-08-08 | Litvack Frank Director | Grant or award · Stock Option (right to buy) | +23,750 | 23,750 | ||
| 2019-08-08 | Musket David B Director | Grant or award · Stock Option (right to buy) | +8,750 | 8,750 | ||
| 2019-08-08 | COLLIER EARL M JR Director | Grant or award · Stock Option (right to buy) | +4,750 | 4,750 | ||
| 2019-08-08 | Bergmann Anthony Chief Financial Officer | Grant or award · Stock Option (right to buy) | +14,000 | 14,000 |
Page 19 of 24 · 468 trades